MIA researchers on Highly Cited 2021 List
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
Drug therapy looks set to become the standard treatment for high-risk early stage melanoma patients.
“The future looks bright – I truly believe that we will get to zero deaths from melanoma with the trajectory we’re following.”
Successful trial of a new immunotherapy drug which offers a third, and less toxic, option for the treatment of advanced melanoma.
MIA Co-Medical Director, Professor Georgina Long, who has been recognised in the 2020 Queen’s Birthday Honours List.
MIA's world leading researchers receive NHMRC grants to further their melanoma research, taking us closer to reaching zero deaths from melanoma.